Literature DB >> 7729289

Functional bowel disorders. A multicenter comparison of health status and development of illness severity index.

D A Drossman1, Z Li, B B Toner, N E Diamant, F H Creed, D Thompson, N W Read, C Babbs, M Barreiro, L Bank.   

Abstract

In a multicenter study of patients with painful functional bowel disorders (FBD), we compared the demographic, health status, and diagnostic features of patients with FBD and developed a functional bowel disorder severity index (FBDSI) for research and clinical care. Two hundred seventy patients with FBD in the United States, England, and Canada were surveyed on symptoms and health status, and their physicians made a diagnosis and rated illness severity as mild, moderate, or severe. Comparisons of 22 demographic and clinical variables were made by study site in addition to physicians' severity ratings. To develop the FBDSI, multiple regression analysis used the demographic and clinical variables to predict the physician's rating of severity. We found that most health status measures of patients with FBD across study sites are comparable and the derived and validated FBDSI scoring system uses three easy to obtain variables: FBDSI = [current pain by visual analog scale (0-100)] + [diagnosis of chronic functional abdominal pain (0 if absent and 106 if present)] + [number of physicians visits over previous six months x 11]. The FBDSI can be used to select patients for research protocols and/or follow their clinical outcome or response to treatments over time.

Entities:  

Mesh:

Year:  1995        PMID: 7729289     DOI: 10.1007/bf02064187

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

Review 1.  The irritable bowel syndrome: review and a graduated multicomponent treatment approach.

Authors:  D A Drossman; W G Thompson
Journal:  Ann Intern Med       Date:  1992-06-15       Impact factor: 25.391

2.  Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters.

Authors:  K W Heaton; L J O'Donnell; F E Braddon; R A Mountford; A O Hughes; P J Cripps
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

3.  Survey of the AGA membership relating to patients with functional gastrointestinal disorders.

Authors:  C M Mitchell; D A Drossman
Journal:  Gastroenterology       Date:  1987-05       Impact factor: 22.682

4.  Sexual and physical abuse in women with functional or organic gastrointestinal disorders.

Authors:  D A Drossman; J Leserman; G Nachman; Z M Li; H Gluck; T C Toomey; C M Mitchell
Journal:  Ann Intern Med       Date:  1990-12-01       Impact factor: 25.391

5.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

6.  Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group.

Authors:  E J Irvine; B Feagan; J Rochon; A Archambault; R N Fedorak; A Groll; D Kinnear; F Saibil; J W McDonald
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

7.  Epidemiology of colonic symptoms and the irritable bowel syndrome.

Authors:  N J Talley; A R Zinsmeister; C Van Dyke; L J Melton
Journal:  Gastroenterology       Date:  1991-10       Impact factor: 22.682

8.  U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact.

Authors:  D A Drossman; Z Li; E Andruzzi; R D Temple; N J Talley; W G Thompson; W E Whitehead; J Janssens; P Funch-Jensen; E Corazziari
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

Review 9.  Basic and clinical aspects of visceral hyperalgesia.

Authors:  E A Mayer; G F Gebhart
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

10.  Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome.

Authors:  D A Drossman; D C McKee; R S Sandler; C M Mitchell; E M Cramer; B C Lowman; A L Burger
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

View more
  41 in total

Review 1.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 2.  Irritable bowel syndrome. Diagnosis in the managed care era.

Authors:  G F Longstreth
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

3.  Validation of the Japanese version of the Rome II modular questionnaire and irritable bowel syndrome severity index.

Authors:  Masae Shinozaki; Motoyori Kanazawa; Yasuhiro Sagami; Yuka Endo; Michio Hongo; Douglas A Drossman; William E Whitehead; Shin Fukudo
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

4.  High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome.

Authors:  Keren Hod; Tamar Ringel-Kulka; Christopher F Martin; Nitsan Maharshak; Yehuda Ringel
Journal:  J Clin Gastroenterol       Date:  2016-03       Impact factor: 3.062

Review 5.  Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.

Authors:  Michael Camilleri; Lin Chang
Journal:  Gastroenterology       Date:  2008-10-09       Impact factor: 22.682

6.  Latent structure of irritable bowel syndrome symptom severity.

Authors:  Fabian Jasper; Boris Egloff; Andrea Roalfe; Michael Witthöft
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

7.  Influence of functional bowel disease on outcome of surgical antireflux procedures.

Authors:  David A Axelrod; Vasu Divi; Majet M Ajluni; Frederic E Eckhauser; Lisa M Colletti
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

8.  The evaluation of constipation.

Authors:  Matthew D Vrees; Eric G Weiss
Journal:  Clin Colon Rectal Surg       Date:  2005-05

9.  Irritable bowel syndrome: diagnosis and pathogenesis.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

10.  A very low-carbohydrate diet improves symptoms and quality of life in diarrhea-predominant irritable bowel syndrome.

Authors:  Gregory L Austin; Christine B Dalton; Yuming Hu; Carolyn B Morris; Jane Hankins; Stephan R Weinland; Eric C Westman; William S Yancy; Douglas A Drossman
Journal:  Clin Gastroenterol Hepatol       Date:  2009-03-10       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.